Dosimetric consequences of image guidance techniques on robust optimized intensity-modulated proton therapy for treatment of breast Cancer
Tóm tắt
To investigate the consequences of residual setup error on target dose distribution using various image registration strategies for breast cancer treated with intensity-modulated proton therapy (IMPT). Among 11 post-lumpectomy patients who received IMPT, 44 dose distributions were computed. For each patient, the original plan (Plan-O) and three verification plans were calculated using different alignments: bony anatomy (VPlan-B), breast tissue (VPlan-T), and skin (VPlan-S). The target coverage were evaluated for each alignment technique. Additionally, 2 subvolumes—BreastNearSkin (1-cm rim of anterior CTV) and BreastNearCW (1-cm rim of posterior CTV)—were created to help localize CTV underdosing. Furthermore, we divided the setup error into the posture error and breast error. Patients with a large posture error and those with good posture setup but a large breast error were identified to evaluate the effect of posture error and breast error. For Plan-O, VPlan-B, VPlan-T, and VPlan-S, respectively, the median (interquartile range) breast CTV D95 was 95.7%(94.7–96.3%), 95.1% (93.9–95.7%), 95.2% (94.8–95.6%), and 95.2% (94.9–95.7%); BreastNearCW D95 was 96.9% (95.6–97.3%), 94.8% (93.5–97.0%), 95.6% (94.8–97.0%), 95.6% (94.8–97.1%); and BreastNearSkin D95 was 94.1% (92.7–94.4%), 93.6% (92.2–94.5%), 93.5% (92.4–94.5%), and 94.4% (92.2–94.5%) of the prescription dose. 4/11 patients had ≥1% decrease in breast CTV D95, 1 of whom developed breast edema while the other 3 all had a > 2o posture error. The CTV D95 variation was within 1% for the patients with good posture setup but >2o breast error. Acceptable target coverage was achieved with all three alignment strategies. Breast tissue and skin alignment maintained the breast target coverage marginally better than bony alignment, with which the posterior CTV along the chest wall is the predominant area affected by under-dosing. For target dose distribution, posture error appears more influential than breast error.
Tài liệu tham khảo
Darby SC, Ewertz M, McGale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368:987–98.
Ares C, Khan S, Macartain AM, et al. Postoperative proton radiotherapy for localized and locoregional breast cancer: potential for clinically relevant improvements? Int J Radiat Oncol Biol Phys. 2010;76:685–97.
MacDonald SM, Patel SA, Hickey S, et al. Proton therapy for breast cancer after mastectomy: early outcomes of a prospective clinical trial. Int J Radiat Oncol Biol Phys. 2013;86:484–90.
Bradley JA, Dagan R, Ho MW, et al. Initial report of a prospective Dosimetric and clinical feasibility trial demonstrates the potential of protons to increase the therapeutic ratio in breast Cancer compared with photons. Int J Radiat Oncol Biol Phys. 2016;95:411–21.
Braunstein LZ, Cahlon O. Potential morbidity reduction with proton radiation therapy for breast Cancer. Semin Radiat Oncol. 2018;28:138–49.
Xu N, Ho MW, Li Z, et al. Can proton therapy improve the therapeutic ratio in breast cancer patients at risk for nodal disease? Am J Clin Oncol. 2014;37:568–74.
Cuaron JJ, Chon B, Tsai H, et al. Early toxicity in patients treated with postoperative proton therapy for locally advanced breast cancer. Int J Radiat Oncol Biol Phys. 2015;92:284–91.
Fagundes M, Hug EB, Pankuch M, et al. Proton therapy for local-regionally, advanced breast Cancer maximizes cardiac sparing. Int J Part Ther. 2015;1:827–44.
Kammerer E, Guevelou JL, Chaikh A, et al. Proton therapy for locally advanced breast cancer: a systematic review of the literature. Cancer Treat Rev. 2018;63:19–27.
Hug EB. Proton therapy for primary breast Cancer. Breast Care (Basel). 2018;13:168–72.
Michalski A, Atyeo J, Cox J, et al. Inter- and intra-fraction motion during radiation therapy to the whole breast in the supine position: a systematic review. J Med Imaging Radiat Oncol. 2012;56:499–509.
Batumalai V, Holloway L, Delaney GP. A review of setup error in supine breast radiotherapy using cone-beam computed tomography. Med Dosim. 2016;41:225–9.
Veiga C, Janssens G, Teng CL, et al. First clinical investigation of cone beam computed tomography and deformable registration for adaptive proton therapy for lung Cancer. Int J Radiat Oncol Biol Phys. 2016;95:549–59.
Wang P, Yin L, Zhang Y, et al. Quantitative assessment of anatomical change using a virtual proton depth radiograph for adaptive head and neck proton therapy. J Appl Clin Med Phys. 2016;17:427–40.
Batin E, Depauw N, MacDonald S, et al. Can surface imaging improve the patient setup for proton postmastectomy chest wall irradiation? Pract Radiat Oncol. 2016;6:e235–41.
Paganetti H. Range uncertainties in proton therapy and the role of Monte Carlo simulations. Phys Med Biol. 2012;57(11):R99–117.
Vinod SK, Jameson MG, Min M, et al. Uncertainties in volume delineation in radiation oncology: a systematic review and recommendations for future studies. Radiother Oncol. 2016;121:169–79.
Hurkmans CW, Borger JH, Pieters BR, et al. Variability in target volume delineation on CT scans of the breast. Int J Radiat Oncol Biol Phys. 2001;50:1366–72.
Hector CL, Webb S, Evans PM. The dosimetric consequences of inter-fractional patient movement on conventional and intensity-modulated breast radiotherapy treatments. Radiother Oncol. 2000;54:57–64.
Baroni G, Garibaldi C, Scabini M, et al. Dosimetric effects within target and organs at risk of interfractional patient mispositioning in left breast cancer radiotherapy. Int J Radiat Oncol Biol Phys. 2004;59:861–71.
Harron EC, McCallum HM, Lambert EL, et al. Dosimetric effects of setup uncertainties on breast treatment delivery. Med Dosim. 2008;33:293–8.
Jain P, Marchant T, Green M, et al. Inter-fraction motion and dosimetric consequences during breast intensity-modulated radiotherapy (IMRT). Radiother Oncol. 2009;90:93–8.
van Mourik A, van Kranen S, den Hollander S, et al. Effects of setup errors and shape changes on breast radiotherapy. Int J Radiat Oncol Biol Phys. 2011;79:1557–64.
Ratosa I, Jenko A, Oblak I. Breast size impact on adjuvant radiotherapy adverse effects and dose parameters in treatment planning. Radiol Oncol. 2018;52(3):233–44.
Guo B, Shah CS, Magnelli A, et al. Surface Guided Radiation Therapy (SGRT): The Sensitivity of the Region of Interest (ROI) Selection on the Translational and Rotational Accuracy for Whole Breast Irradiation. Int J Radiat Oncol Biol Phys. 2011;2017(99):E666–7.